BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, Egeblad M, Henneck T, Hidalgo A, Hoffmann M, Hohberger B, Kanthi Y, Kaplan MJ, Knight JS, Knopf J, Kolaczkowska E, Kubes P, Leppkes M, Mahajan A, Manfredi AA, Maueröder C, Maugeri N, Mitroulis I, Muñoz LE, Narasaraju T, Naschberger E, Neeli I, Ng LG, Radic MZ, Ritis K, Rovere-Querini P, Schapher M, Schauer C, Simon HU, Singh J, Skendros P, Stark K, Stürzl M, van der Vlag J, Vandenabeele P, Vitkov L, von Köckritz-Blickwede M, Yanginlar C, Yousefi S, Zarbock A, Schett G, Herrmann M. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 2021. [PMID: 34031543 DOI: 10.1038/s41418-021-00805-z] [Cited by in Crossref: 91] [Cited by in F6Publishing: 103] [Article Influence: 91.0] [Reference Citation Analysis]
Number Citing Articles
1 Ciccosanti F, Antonioli M, Sacchi A, Notari S, Farina A, Beccacece A, Fusto M, Vergori A, D’offizi G, Taglietti F, Antinori A, Nicastri E, Marchioni L, Palmieri F, Ippolito G, Piacentini M, Agrati C, Fimia GM. Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. Clin Proteom 2022;19:38. [DOI: 10.1186/s12014-022-09377-7] [Reference Citation Analysis]
2 Silva CMS, Wanderley CWS, Veras FP, Gonçalves AV, Lima MHF, Toller-kawahisa JE, Gomes GF, Nascimento DC, Monteiro VVS, Paiva IM, Almeida CJLR, Caetité DB, Silva JC, Lopes MIF, Bonjorno LP, Giannini MC, Amaral NB, Benatti MN, Santana RC, Damasceno LEA, Silva BMS, Schneider AH, Castro IMS, Silva JCS, Vasconcelos AP, Gonçalves TT, Batah SS, Rodrigues TS, Costa VF, Pontelli MC, Martins RB, Martins TV, Espósito DLA, Cebinelli GCM, da Fonseca BAL, Leiria LOS, Cunha LD, Arruda E, Nakaia HI, Fabro AT, Oliveira RDR, Zamboni DS, Louzada-junior P, Cunha TM, Alves-filho JCF, Cunha FQ. Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology. Crit Care 2022;26:206. [DOI: 10.1186/s13054-022-04062-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Li X, Ye Y, Peng K, Zeng Z, Chen L, Zeng Y. Histones: The critical players in innate immunity. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1030610] [Reference Citation Analysis]
4 Bradic M, Taleb S, Thomas B, Chidiac O, Robay A, Hassan N, Malek J, Ait Hssain A, Abi Khalil C. DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome. J Transl Med 2022;20:526. [DOI: 10.1186/s12967-022-03737-5] [Reference Citation Analysis]
5 Gao Y, Cai L, Li L, Zhang Y, Li J, Luo C, Wang Y, Tao L. Emerging Effects of IL-33 on COVID-19. IJMS 2022;23:13656. [DOI: 10.3390/ijms232113656] [Reference Citation Analysis]
6 Sokolov AV, Isakova-Sivak IN, Mezhenskaya DA, Kostevich VA, Gorbunov NP, Elizarova AY, Matyushenko VA, Berson YM, Grudinina NA, Kolmakov NN, Zabrodskaya YA, Komlev AS, Semak IV, Budevich AI, Rudenko LG, Vasilyev VB. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin. Biometals 2022. [PMID: 36334191 DOI: 10.1007/s10534-022-00458-6] [Reference Citation Analysis]
7 Jiang C, Jiang K, Li X, Zhang N, Zhu W, Meng L, Zhang Y, Lu S. Evaluation of immunoprotection against coronavirus disease 2019: Novel variants, vaccine inoculation, and complications. J Pharm Anal 2022. [PMID: 36317070 DOI: 10.1016/j.jpha.2022.10.003] [Reference Citation Analysis]
8 Sun Y, Zou Y, Wang H, Cui G, Yu Z, Ren Z. Immune response induced by novel coronavirus infection. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.988604] [Reference Citation Analysis]
9 Pishesha N, Harmand T, Carpenet C, Liu X, Bhan A, Islam A, van den Doel R, Pinney W 3rd, Ploegh HL. Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms. Proc Natl Acad Sci U S A 2022;119:e2211065119. [PMID: 36252038 DOI: 10.1073/pnas.2211065119] [Reference Citation Analysis]
10 Minamimoto R. Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data. Front Med 2022;9:1052921. [DOI: 10.3389/fmed.2022.1052921] [Reference Citation Analysis]
11 Musiał K. Update on Innate Immunity in Acute Kidney Injury—Lessons Taken from COVID-19. IJMS 2022;23:12514. [DOI: 10.3390/ijms232012514] [Reference Citation Analysis]
12 Yeung ST, Premeaux TA, Du L, Niki T, Pillai SK, Khanna KM, Ndhlovu LC. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection. Front Immunol 2022;13:1011185. [DOI: 10.3389/fimmu.2022.1011185] [Reference Citation Analysis]
13 Zhang Q, Zhang H, Yan X, Ma S, Yao X, Shi Y, Ping Y, Cao M, Peng C, Wang S, Luo M, Yan C, Zhang S, Han Y, Bian X. Neutrophil infiltration and myocarditis in patients with severe COVID-19: A post-mortem study. Front Cardiovasc Med 2022;9:1026866. [PMID: 36312241 DOI: 10.3389/fcvm.2022.1026866] [Reference Citation Analysis]
14 Ngo ATP, Gollomp K. Building a better NET : Neutrophil extracellular trap targeted therapeutics in the treatment of infectious and inflammatory disorders. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12808] [Reference Citation Analysis]
15 Damascena HL, Silveira WAA, Castro MS, Fontes W. Neutrophil Activated by the Famous and Potent PMA (Phorbol Myristate Acetate). Cells 2022;11:2889. [DOI: 10.3390/cells11182889] [Reference Citation Analysis]
16 Loh JT, Teo JKH, Lam K. Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein. Front Immunol 2022;13:996637. [DOI: 10.3389/fimmu.2022.996637] [Reference Citation Analysis]
17 Konlaan Y, Asamoah Sakyi S, Kumi Asare K, Amoah Barnie P, Opoku S, Nakotey GK, Victor Nuvor S, Amoani B. Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana. PLoS ONE 2022;17:e0273969. [DOI: 10.1371/journal.pone.0273969] [Reference Citation Analysis]
18 Wang J, Li Q, Qiu Y, Lu H. COVID-19: imbalanced cell-mediated immune response drives to immunopathology. Emerg Microbes Infect 2022;:1-28. [PMID: 36069182 DOI: 10.1080/22221751.2022.2122579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Keir HR, Long MB, Abo-leyah H, Giam YH, Vadiveloo T, Pembridge T, Hull RC, Delgado L, Band M, Mclaren-neil F, Adamson S, Lahnsteiner E, Gilmour A, Hughes C, New BJ, Connell D, Dowey R, Turton H, Richardson H, Cassidy D, Cooper J, Suntharalingam J, Diwakar L, Russell P, Underwood J, Hicks A, Dosanjh DP, Sage B, Dhasmana D, Spears M, Thompson AR, Brightling C, Smith A, Patel M, George J, Condliffe AM, Shoemark A, Maclennan G, Chalmers JD, Chalmers J, Abo-leyah H, New BJ, Almaden-boyle C, Connell D, Taylor J, Strachan J, Loftus H, Young L, Strachan A, Band M, Mclaren-neil F, Pilvinyte K, Adamson S, Lahnsteiner E, Rauchhaus P, Hogarth F, George J, Burns T, Coote E, Keiller M, Patel M, Smith A, Sage E, Cooper J, Miller D, Dosanjh D, Sutton B, Underwood J, Frayling S, Haynes M, Broad L, Jones L, Rahilly K, Oliver C, Evans T, Balan A, Davies R, Forde D, Nye C, Haboubi D, Hilton Z, Williams J, Mcqueen A, Spears M, Edmond I, Salutous D, Mcgenily L, Scott R, Henderson E, Collins A, Dhasmana D, Liu P, Morrow A, Couser M, Davey F, Hicks A, Wiffen L, Fox L, Abdelrahim M, Darbyshire A, Cowen E, Rowley M, Giles B, Yang Y, Brown T, Rupani H, Hawes E, Barnes D, Brogan F, Bungue-tuble R, Howe S, Turner C, Baryschpolec S, Longhurst B, Moon M, Watkins L, Baker-moffat M, Murray L, Harrington-davies Y, Burrows K, Minnis C, Wands M, Bamgboye A, Wong C, Brightling C, Diver S, Russell R, Mcauley H, Elneima O, Yousuf A, Mccourt P, Hargadon B, Parker S, Bourne M, Suntharalingam J, Hartley T, Masan V, Sturney S, Mackenzie R, Marchand C, Mason R, White K, Kirby A, Meda M, Diwakar L, Russell P, Finn J, Harris S, Muir C, Cook G, Staines N, Cook C, Thompson AR, Condliffe A, Hull R, Dowey R, Turton H, Collini P, Gabriel Z, Hardman S, Newell H, Middle J, Simpson P, Colton H, Barker J, Birchall K, Harrington K, Housley K, Lenagh R, Wilson J, Wesonga J, Whitham R, Bird S, Jackson Y, Mbuyisa A, Anderson S, Wilson A, Kibutu F, Walker S, Cawthron K, Macharia I, Smart L, Emery A, Howell A, Hurditch E, Ford A, Turner K, Watson L, Bowler H, Jackson T, Jaques C, Dyer N, Ducker S, Goodall V, Udale E. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00261-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kaplan MJ. Casting a Wide NET. J I 2022;209:843-844. [DOI: 10.4049/jimmunol.2200173] [Reference Citation Analysis]
21 Han T, Tang H, Lin C, Shen Y, Yan D, Tang X, Guo D. Extracellular traps and the role in thrombosis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.951670] [Reference Citation Analysis]
22 Knopf J, Sjöwall J, Frodlund M, Hinkula J, Herrmann M, Sjöwall C. NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic. Cells 2022;11:2619. [DOI: 10.3390/cells11172619] [Reference Citation Analysis]
23 Majchrzak M, Poręba M. The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic. Pharmacol Rep 2022. [PMID: 35997950 DOI: 10.1007/s43440-022-00394-9] [Reference Citation Analysis]
24 Skendros P, Germanidis G, Mastellos DC, Antoniadou C, Gavriilidis E, Kalopitas G, Samakidou A, Liontos A, Chrysanthopoulou A, Ntinopoulou M, Kogias D, Karanika I, Smyrlis A, Cepaityte D, Fotiadou I, Zioga N, Mitroulis I, Gatselis NK, Papagoras C, Metallidis S, Milionis H, Dalekos GN, Willems L, Persson B, Manivel VA, Nilsson B, Connolly ES, Iacobelli S, Papadopoulos V, Calado RT, Huber-Lang M, Risitano AM, Yancopoulou D, Ritis K, Lambris JD. Complement C3 inhibition in severe COVID-19 using compstatin AMY-101. Sci Adv 2022;8:eabo2341. [PMID: 35977025 DOI: 10.1126/sciadv.abo2341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Xu X, Feng Y, Jia Y, Zhang X, Li L, Bai X, Jiao L. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis. Thromb Res 2022;218:83-98. [PMID: 36027630 DOI: 10.1016/j.thromres.2022.08.017] [Reference Citation Analysis]
26 Zabrodskaya YA, Egorov VV, Sokolov AV, Shvetsov AV, Gorshkova YE, Ivankov OI, Kostevich VA, Gorbunov NP, Ramsay ES, Fedorova ND, Bondarenko AB, Vasilyev VB. Caught red handed: modeling and confirmation of the myeloperoxidase ceruloplasmin alpha-thrombin complex. Biometals 2022. [PMID: 35962914 DOI: 10.1007/s10534-022-00432-2] [Reference Citation Analysis]
27 Alkahtani AM, Alraey Y, Zaman GS, Al‐shehri H, Alghamdi IS, Chandramoorthy HC, Al-hakami AM, Alamri AM, Alshehri HA. . JBM 2022;Volume 13:447-59. [DOI: 10.2147/jbm.s365218] [Reference Citation Analysis]
28 Dutta K, Friscic J, Hoffmann MH. Targeting the tissue-complosome for curbing inflammatory disease. Semin Immunol 2022;:101644. [PMID: 35902311 DOI: 10.1016/j.smim.2022.101644] [Reference Citation Analysis]
29 Liu Q, Zhu C, Li H, Xie J, Guo Y, Li P, Zhao Z, Wang J, Deng X, Xu Q. Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/7411824] [Reference Citation Analysis]
30 Ligi D, Giglio RV, Henry BM, Lippi G, Ciaccio M, Plebani M, Mannello F. What is the impact of circulating histones in COVID-19: a systematic review. Clinical Chemistry and Laboratory Medicine (CCLM) 2022;0. [DOI: 10.1515/cclm-2022-0574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Lee LE, Jeong W, Park YB, Jeong SJ, Lee SW. Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2. J Clin Med 2022;11:4152. [PMID: 35887916 DOI: 10.3390/jcm11144152] [Reference Citation Analysis]
32 Sharma A, Chauhan A, Chauhan P, Evans DL, Szlabick RE, Aaland MO, Mishra BB, Sharma J. Glycolipid Metabolite β-Glucosylceramide Is a Neutrophil Extracellular Trap–Inducing Ligand of Mincle Released during Bacterial Infection and Inflammation. J I 2022;209:391-400. [DOI: 10.4049/jimmunol.2100855] [Reference Citation Analysis]
33 Paclet M, Laurans S, Dupré-crochet S. Regulation of Neutrophil NADPH Oxidase, NOX2: A Crucial Effector in Neutrophil Phenotype and Function. Front Cell Dev Biol 2022;10:945749. [DOI: 10.3389/fcell.2022.945749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Narang J, Jatana S, Ponti AK, Musich R, Gallop J, Wei AH, Seck S, Johnson J, Kokoczka L, Nowacki AS, Mcbride JD, Mireles-cabodevila E, Gordon S, Cooper K, Fernandez AP, Mcdonald C. Abnormal thrombosis and neutrophil activation increases the risk of hospital-acquired sacral pressure injuries and morbidity in patients with COVID-19.. [DOI: 10.1101/2022.07.07.22277374] [Reference Citation Analysis]
35 Silva BM, Veras FP, Gomes GF, Cambier S, Silva GVL, Quadros AU, Caetité DB, Nascimento DC, Silva CM, Silva JC, Damasceno S, Schneider AH, Beretta F, Batah SS, Castro IMS, Paiva IM, Rodrigues T, Salina A, Martins R, Cebinelli GC, Bibo NL, Jorge DM, Nakaya HI, Zamboni DS, Leiria LO, Fabro AT, Alves-filho JC, Arruda E, Louzada-junior P, Oliveira RD, Cunha LD, Mol PV, Vanderbeke L, Feys S, Wauters E, Brandolini L, Cunha FQ, Köhl J, Allegretti M, Lambrechts D, Wauters J, Proost P, Cunha TM. Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology.. [DOI: 10.1101/2022.07.03.498624] [Reference Citation Analysis]
36 Deretic V, Lazarou M. A guide to membrane atg8ylation and autophagy with reflections on immunity. J Cell Biol 2022;221:e202203083. [PMID: 35699692 DOI: 10.1083/jcb.202203083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Szewczykowski C, Mardin C, Lucio M, Wallukat G, Hoffmanns J, Schröder T, Raith F, Rogge L, Heltmann F, Moritz M, Beitlich L, Schottenhamml J, Herrmann M, Harrer T, Ganslmayer M, Kruse FE, Kräter M, Guck J, Lämmer R, Zenkel M, Gießl A, Hohberger B. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. IJMS 2022;23:7209. [DOI: 10.3390/ijms23137209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
38 Ventura-Santana E, Ninan JR, Snyder CM, Okeke EB. Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand. Front Immunol 2022;13:902206. [PMID: 35757734 DOI: 10.3389/fimmu.2022.902206] [Reference Citation Analysis]
39 Jonigk D, Werlein C, Lee PD, Kauczor H, Länger F, Ackermann M. Pulmonary and systemic pathology in COVID-19—holistic pathological analyses. Deutsches Ärzteblatt international 2022. [DOI: 10.3238/arztebl.m2022.0231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
41 Zhu Z, Shi J, Li L, Wang J, Zhao Y, Ma H. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. Front Immunol 2022;13:870216. [PMID: 35655782 DOI: 10.3389/fimmu.2022.870216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, Goodridge HS, Granot Z, Hidalgo A, Huttenlocher A, Kaplan MJ, Malanchi I, Merghoub T, Meylan E, Mittal V, Pittet MJ, Rubio-Ponce A, Udalova IA, van den Berg TK, Wagner DD, Wang P, Zychlinsky A, de Visser KE, Egeblad M, Kubes P. Neutrophil phenotypes and functions in cancer: A consensus statement. J Exp Med 2022;219:e20220011. [PMID: 35522219 DOI: 10.1084/jem.20220011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
43 Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, Jiang J, Shao C, Li P, He X, Hua F, Niu Z, Ma C, Zhu Y, Ippolito G, Piacentini M, Estaquier J, Melino S, Weiss FD, Andreano E, Latz E, Schultze JL, Rappuoli R, Mantovani A, Mak TW, Melino G, Shi Y. Immune response in COVID-19: what is next? Cell Death Differ 2022;29:1107-22. [PMID: 35581387 DOI: 10.1038/s41418-022-01015-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
44 Palacios Y, Chavez-galan L. Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? Pharmaceuticals 2022;15:616. [DOI: 10.3390/ph15050616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 D’amato M, Vertui V, Pandolfi L, Bozzini S, Fossali T, Colombo R, Aliberti A, Fumagalli M, Iadarola P, Didò C, Viglio S, Meloni F. Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients. CIMB 2022;44:2122-38. [DOI: 10.3390/cimb44050143] [Reference Citation Analysis]
46 Romano A, Parrinello NL, Barchitta M, Manuele R, Puglisi F, Maugeri A, Barbato A, Triolo AM, Giallongo C, Tibullo D, La Ferla L, Botta C, Siragusa S, Iacobello C, Montineri A, Volti GL, Agodi A, Palumbo GA, Di Raimondo F. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection. Sci Rep 2022;12:7237. [PMID: 35508575 DOI: 10.1038/s41598-022-11157-0] [Reference Citation Analysis]
47 Mizutani T. A Reciprocal Cross-Reactivity between Monoclonal Antibodies to SARS-CoV-2 Spike Glycoprotein S1 and Human CXCR2—An Implication of a Viral Mimic of Human CXCR2. COVID 2022;2:569-577. [DOI: 10.3390/covid2050042] [Reference Citation Analysis]
48 Vollbracht C, Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front Pharmacol 2022;13:899198. [DOI: 10.3389/fphar.2022.899198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
49 De Lorenzo R, Sciorati C, Ramirez GA, Colombo B, Lorè NI, Capobianco A, Tresoldi C, Cirillo DM, Ciceri F, Corti A, Rovere-Querini P, Manfredi AA; Bio Angels for COVID-BioB Study Group. Chromogranin A plasma levels predict mortality in COVID-19. PLoS One 2022;17:e0267235. [PMID: 35468164 DOI: 10.1371/journal.pone.0267235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cuppen JJM, Gradinaru C, Raap-van Sleuwen BE, de Wit ACE, van der Vegt TAAJ, Savelkoul HFJ. LF-EMF Compound Block Type Signal Activates Human Neutrophilic Granulocytes In Vivo. Bioelectromagnetics 2022. [PMID: 35481557 DOI: 10.1002/bem.22406] [Reference Citation Analysis]
51 Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, Zioga N, Kogias D, Natsi AM, Pelekoudas C, Satiridou E, Bakola SA, Papagoras C, Mitroulis I, Peichamperis P, Mikroulis D, Papadopoulos V, Skendros P, Ritis K. Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure. Clin Immunol 2022;:109016. [PMID: 35447311 DOI: 10.1016/j.clim.2022.109016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
52 Junqueira C, Crespo Â, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, Ho F, Beakes C, Margolin J, Russell N, Kays K, Boucau J, Das Adhikari U, Vora SM, Leger V, Gehrke L, Henderson LA, Janssen E, Kwon D, Sander C, Abraham J, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Filbin MR, Lieberman J. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 2022. [PMID: 35385861 DOI: 10.1038/s41586-022-04702-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 90] [Article Influence: 80.0] [Reference Citation Analysis]
53 Zhang Q, Ling S, Hu K, Liu J, Xu J. Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19). Biomedicine & Pharmacotherapy 2022;148:112718. [DOI: 10.1016/j.biopha.2022.112718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Mortezaee K, Majidpoor J. CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives. Front Immunol 2022;13:864298. [DOI: 10.3389/fimmu.2022.864298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
55 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
56 Ligi D, Maniscalco R, Plebani M, Lippi G, Mannello F. Do Circulating Histones Represent the Missing Link among COVID-19 Infection and Multiorgan Injuries, Microvascular Coagulopathy and Systemic Hyperinflammation? J Clin Med 2022;11:1800. [PMID: 35407410 DOI: 10.3390/jcm11071800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Zhu Y, Chen X, Liu X. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond. Front Immunol 2022;13:838011. [PMID: 35309344 DOI: 10.3389/fimmu.2022.838011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
58 Jang H, Choudhury S, Yu Y, Sievers BL, Gelbart T, Singh H, Rawlings SA, Proal A, Tan GS, Smith D, Freire M. Persistent Immune and Clotting Dysfunction Detected in Saliva and Blood Plasma after COVID-19.. [DOI: 10.1101/2022.03.18.484814] [Reference Citation Analysis]
59 Noll J, Reichert M, Dietrich M, Riedel JG, Hecker M, Padberg W, Weigand MA, Hecker A. When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02495-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther 2022;13:122. [PMID: 35313959 DOI: 10.1186/s13287-022-02796-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bader SM, Cooney JP, Pellegrini M, Doerflinger M. Programmed cell death: the pathways to severe COVID-19? Biochem J 2022;479:609-28. [PMID: 35244141 DOI: 10.1042/BCJ20210602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
62 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Henneck T, Mergani A, Clever S, Seidler AE, Brogden G, Runft S, Baumgärtner W, Branitzki-Heinemann K, von Köckritz-Blickwede M. Formation of Neutrophil Extracellular Traps by Reduction of Cellular Cholesterol Is Independent of Oxygen and HIF-1α. Int J Mol Sci 2022;23:3195. [PMID: 35328617 DOI: 10.3390/ijms23063195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, Zioga N, Kogias D, Natsi A, Pelekoudas C, Satiridou E, Bakola S, Papagoras C, Mitroulis I, Peichamperis P, Mikroulis D, Papadopoulos V, Skendros P, Ritis K. Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure.. [DOI: 10.1101/2022.03.14.22270915] [Reference Citation Analysis]
65 Niederreiter J, Eck C, Ries T, Hartmann A, Märkl B, Büttner-Herold M, Amann K, Daniel C. Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19. Front Immunol 2022;13:835156. [PMID: 35237273 DOI: 10.3389/fimmu.2022.835156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
66 Schimke LF, Marques AHC, Baiocchi GC, de Souza Prado CA, Fonseca DLM, Freire PP, Rodrigues Plaça D, Salerno Filgueiras I, Coelho Salgado R, Jansen-Marques G, Rocha Oliveira AE, Peron JPS, Cabral-Miranda G, Barbuto JAM, Camara NOS, Calich VLG, Ochs HD, Condino-Neto A, Overmyer KA, Coon JJ, Balnis J, Jaitovich A, Schulte-Schrepping J, Ulas T, Schultze JL, Nakaya HI, Jurisica I, Cabral-Marques O. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States. Cells 2022;11:847. [PMID: 35269470 DOI: 10.3390/cells11050847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
67 Xiao F, Wu L, Zhu X, Zhang L, Liu D, Wu L, Zou H, Lu L. Interleukin-6 blocking therapy for COVID-19: From immune pathogenesis to clinical outcomes. Rheumatol Immunol Res 2022;3:11-6. [PMID: 35772080 DOI: 10.2478/rir-2022-0002] [Reference Citation Analysis]
68 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
69 Loh JT, Zhang B, Teo JKH, Lai RC, Choo ABH, Lam KP, Lim SK. Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes. Cytotherapy 2022:S1465-3249(22)00018-4. [PMID: 35177337 DOI: 10.1016/j.jcyt.2021.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
70 Campello E, Radu CM, Simion C, Spiezia L, Bulato C, Gavasso S, Tormene D, Perin N, Turatti G, Simioni P. Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19. Front Cell Dev Biol 2021;9:770463. [PMID: 35111751 DOI: 10.3389/fcell.2021.770463] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
71 Silva CM, Wanderley CWS, Veras FP, Gonçalves AV, Lima MHF, Toller Kawahisa JE, Gomes GF, Nascimento DC, Silva Monteiro VV, Paiva IM, Almeida CJLR, Caetité DB, Silva JDC, Lopes MIF, Bonjorno LP, Giannini MC, Amaral NB, Benatti MN, Damasceno LEA, Silva BMS, Schneider AH, Castro IMS, Silva JCS, Vasconcelos AP, Gonçalves TT, Batah SS, Rodrigues TS, Costa VF, Pontelli MC, Martins RB, Martins TV, Espósito DLA, Cebinelli GCM, da Fonseca BAL, Leiria LOS, Cunha LD, Arruda E, Nakaia HI, Fabro AT, Oliveira RD, Zamboni DS, Junior PL, Cunha TM, Alves Filho JCF, Cunha FDQ. Gasdermin-D activation by SARS-CoV-2 trigger NET and mediate COVID-19 immunopathology.. [DOI: 10.1101/2022.01.24.22269768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Wang C, Cheng S, Kuo S. Asthma and COVID-19 Associations: Focus on IgE-Related Immune Pathology. Life 2022;12:153. [DOI: 10.3390/life12020153] [Reference Citation Analysis]
73 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Zhang Y, Wang Q, Mackay CR, Ng LG, Kwok I. Neutrophil subsets and their differential roles in viral respiratory diseases. J Leukoc Biol 2022. [PMID: 35040189 DOI: 10.1002/JLB.1MR1221-345R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kaplan MJ. Mitochondria shape neutrophils during hypoxia. Blood 2022;139:159-60. [PMID: 35024809 DOI: 10.1182/blood.2021013440] [Reference Citation Analysis]
76 Ciurkiewicz M, Armando F, Schreiner T, de Buhr N, Pilchová V, Krupp-Buzimikic V, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W, Schulz C, Gerhauser I. Ferrets are valuable models for SARS-CoV-2 research. Vet Pathol 2022;:3009858211071012. [PMID: 35001763 DOI: 10.1177/03009858211071012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
77 Nguyen VT, Chan LS. COVID-19 Infection: The Virus and Its Origin, the Variants, the Immune Defense, the Multiorgan Autoimmune Reactions, and the Targeted Treatments. AID 2022;12:568-631. [DOI: 10.4236/aid.2022.123042] [Reference Citation Analysis]
78 Bouillon R, Quesada-Gomez JM. Vitamin D Endocrine System and COVID-19. JBMR Plus 2021;5:e10576. [PMID: 34950831 DOI: 10.1002/jbm4.10576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
79 Elliott W Jr, Guda MR, Asuthkar S, Teluguakula N, Prasad DVR, Tsung AJ, Velpula KK. PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis. Biomedicines 2021;9:1867. [PMID: 34944683 DOI: 10.3390/biomedicines9121867] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
80 Kadkhoda K. Post RNA-based COVID vaccines myocarditis: Proposed mechanisms. Vaccine 2021:S0264-410X(21)01594-2. [PMID: 34895937 DOI: 10.1016/j.vaccine.2021.11.093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
81 Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, Heltmann F, Moritz M, Szewczykowski C, Schottenhamml J, Kräter M, Bergua A, Zenkel M, Gießl A, Schlötzer-Schrehardt U, Lämmer R, Herrmann M, Haberland A, Göttel P, Müller J, Wallukat G. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front Med (Lausanne) 2021;8:754667. [PMID: 34869451 DOI: 10.3389/fmed.2021.754667] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
82 Rawat K, Syeda S, Shrivastava A. Hyperactive neutrophils infiltrate vital organs of tumor bearing host and contribute to gradual systemic deterioration via upregulated NE, MPO and MMP-9 activity. Immunol Lett 2021;241:35-48. [PMID: 34890699 DOI: 10.1016/j.imlet.2021.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
83 Mobarki AA, Dobie G, Saboor M, Madkhali AM, Akhter MS, Hakamy A, Humran A, Hamali Y, Jackson DE, Hamali HA. MPR and NLR as Prognostic Markers in ICU-Admitted Patients with COVID-19 in Jazan, Saudi Arabia. Infect Drug Resist 2021;14:4859-64. [PMID: 34848978 DOI: 10.2147/IDR.S342259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
84 Chen T, Li Y, Sun R, Hu H, Liu Y, Herrmann M, Zhao Y, Muñoz LE. Receptor-Mediated NETosis on Neutrophils. Front Immunol 2021;12:775267. [PMID: 34804066 DOI: 10.3389/fimmu.2021.775267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
85 Long MB, Chalmers JD. Treating Neutrophilic Inflammation in Airways Diseases. Arch Bronconeumol 2021. [PMID: 34866748 DOI: 10.1016/j.arbres.2021.11.003] [Reference Citation Analysis]
86 Maugeri N, De Lorenzo R, Clementi N, Antonia Diotti R, Criscuolo E, Godino C, Tresoldi C, Angels For Covid-BioB Study Group B, Bonini C, Clementi M, Mancini N, Ciceri F, Rovere-Querini P, Manfredi AA. Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19. J Thromb Haemost 2021. [PMID: 34710269 DOI: 10.1111/jth.15575] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
87 Kadkhoda K, Laurita K. Antineutrophil cytoplasmic antibodies and their association with clinical outcomes in hospitalized COVID-19 patients. Cell Death Discov 2021;7:277. [PMID: 34611135 DOI: 10.1038/s41420-021-00671-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Krampert L, Bauer K, Ebner S, Neubert P, Ossner T, Weigert A, Schatz V, Toelge M, Schröder A, Herrmann M, Schnare M, Dorhoi A, Jantsch J. High Na+ Environments Impair Phagocyte Oxidase-Dependent Antibacterial Activity of Neutrophils. Front Immunol 2021;12:712948. [PMID: 34566968 DOI: 10.3389/fimmu.2021.712948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Balzanelli MG, Distratis P, Dipalma G, Vimercati L, Catucci O, Amatulli F, Cefalo A, Lazzaro R, Palazzo D, Aityan SK, Pricolo G, Prudenzano A, D'Errico P, Laforgia R, Pezzolla A, Tomassone D, Inchingolo AD, Pham VH, Iacobone D, Materi GM, Scarano A, Lorusso F, Inchingolo F, Nguyen KCD, Isacco CG. Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups. Microorganisms 2021;9:2036. [PMID: 34683357 DOI: 10.3390/microorganisms9102036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
90 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
91 Yaykasli KO, Schauer C, Muñoz LE, Mahajan A, Knopf J, Schett G, Herrmann M. Neutrophil Extracellular Trap-Driven Occlusive Diseases. Cells 2021;10:2208. [PMID: 34571857 DOI: 10.3390/cells10092208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
92 Schimke LF, Marques AH, Baiocchi GC, de Souza Prado CA, Fonseca DLM, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Jansen-marques G, Oliveira AER, Peron JPS, Cabral-miranda G, Barbuto JAM, Camara NOS, Calich VLG, Ochs HD, Condino-neto A, Overmyer KA, Coon JJ, Balnis J, Jaitovich A, Schulte-schrepping J, Ulas T, Schultze JL, Nakaya HI, Jurisica I, Cabral-marques O. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states.. [DOI: 10.1101/2021.07.30.454529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Giuffrè M, Vetrugno L, Di Bella S, Moretti R, Berretti D, Crocè LS. Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature. Healthcare (Basel) 2021;9:956. [PMID: 34442092 DOI: 10.3390/healthcare9080956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
94 Conceição-Silva F, Reis CSM, De Luca PM, Leite-Silva J, Santiago MA, Morrot A, Morgado FN. The Immune System Throws Its Traps: Cells and Their Extracellular Traps in Disease and Protection. Cells 2021;10:1891. [PMID: 34440659 DOI: 10.3390/cells10081891] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
95 Hohberger B, Ganslmayer M, Lucio M, Kruse F, Hoffmanns J, Moritz M, Rogge L, Heltmann F, Szewczykowski C, Fürst J, Raftis M, Bergua A, Zenkel M, Gießl A, Schlötzer-Schrehardt U, Lehmann P, Strauß R, Mardin C, Herrmann M. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Med (Lausanne) 2021;8:676554. [PMID: 34307408 DOI: 10.3389/fmed.2021.676554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
96 George ST, Lai J, Ma J, Stacey HD, Miller MS, Mullarkey CE. Neutrophils and Influenza: A Thin Line between Helpful and Harmful. Vaccines (Basel) 2021;9:597. [PMID: 34199803 DOI: 10.3390/vaccines9060597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
97 Farouk AF, Shafqat A, Shafqat S, Kashir J, Alkattan K, Yaqinuddin A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, Medical College, Aga Khan University, Karachi, Pakistan, Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. . AIMSMOLES 2021;8:275-90. [DOI: 10.3934/molsci.2021021] [Reference Citation Analysis]